BioHarvest Sciences Inc.
BHSC
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 3.24M | 2.75M | 2.16M | 2.44M | 1.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.24M | 2.75M | 2.16M | 2.44M | 1.52M |
| Cost of Revenue | 1.80M | 1.64M | 1.37M | 1.78M | 1.24M |
| Gross Profit | 1.44M | 1.11M | 792.00K | 666.00K | 274.00K |
| SG&A Expenses | 2.56M | 3.17M | 2.72M | 2.64M | 2.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.25M | 5.63M | 4.70M | 4.98M | 4.49M |
| Operating Income | -2.01M | -2.88M | -2.54M | -2.54M | -2.98M |
| Income Before Tax | -1.73M | -2.85M | -752.00K | -2.81M | -3.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.73M | -2.85M | -752.00K | -2.81M | -3.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.73M | -2.85M | -752.00K | -2.81M | -3.92M |
| EBIT | -2.01M | -2.88M | -2.54M | -2.54M | -2.98M |
| EBITDA | -1.79M | -2.67M | -2.34M | -2.47M | -2.78M |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 469.72M | 469.64M | 465.72M | 445.36M | 458.01M |
| Average Diluted Shares Outstanding | 469.72M | 469.64M | 465.72M | 445.36M | 458.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
